UC Investments
Oakland, California, United StatesFounded 1978
UC Investments focuses on a "Less is More" strategy, emphasizing simplification, risk management, and a concentrated portfolio with a significant allocation to passive investments in public index funds. Their strategy also includes a commitment to long-term value creation, sustainability by avoiding fossil fuel investments, and leveraging the University of California's ecosystem for opportunities in areas like technology, life sciences, and climate change solutions.
38% of their portfolio is in Healthcare. Deal activity increased 50% year-over-year (3 deals in the last 12 months). Average disclosed round size is $313.7M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
$153B
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Prenosis | Series A | $20M | Jan 2026 |
 LMArena | Series C | $150M | Jan 2026 |
| LMArena | Seed | $100M | May 2025 |
 Bright Uro | Series A | $32M | Oct 2024 |
| DDigestiva | Series A | $18.4M | Jul 2024 |
 Eikon Therapeutics | Series B | $517.8M | Jan 2022 |
 Databricks | Series H | $1.6B | Aug 2021 |
 A2 Biotherapeutics | Series B | $71.5M | Oct 2020 |
Top Co-Investors
Andreessen Horowitz3 shared
The Column Group2 shared
Lightspeed Venture Partners2 shared
Felicis Ventures2 shared
Kleiner Perkins2 shared
The House Fund2 shared
Labcorp1 shared
Samsara BioCapital1 shared
Nextech Invest1 shared
Casdin Capital1 shared
Euclidean Capital1 shared
March Capital Partners1 shared
Astanor1 shared
LDVP1 shared
Laude1 shared
Lux Capital1 shared
T. Rowe Price1 shared
General Catalyst1 shared
Abu Dhabi Investment Authority1 shared
Last updated: 12 April 2026